Skip to main content

Che-Chia Hsu

Assistant Professor of Pathology
Pathology
210 Research Dr, GSRB2 Building, Room 4014, Durham, NC 27710
210 Research Drive, GSRB2 Building, Room 4014, Durham, NC 27710

Overview


My research has focused on mitochondrial functions in cancer metabolism and understand the role of mitochondrial dynamics in cellular function and human diseases including cancers. Additionally, I also continuously dissect cancer metabolism and identifying potential metabolic vulnerabilities of cancer initiation, progression and metastasis using several in vitroex vivo and in vivo genetical approaches such as CRISPR/Cas9 knockout, mouse/ human organoid cultures and genetically engineered mouse models, thereby characterizing molecular mechanisms regulated by metabolic pathways and developing potential metabolic interventions for targeting cancers. 

Current Appointments & Affiliations


Assistant Professor of Pathology · 2023 - Present Pathology, Clinical Science Departments
Member of the Duke Cancer Institute · 2024 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Glucose metabolism and its direct action in cancer and immune regulation: opportunities and challenges for metabolic targeting.

Journal Article J Biomed Sci · July 29, 2025 Glucose metabolism is a pivotal hub for cellular energy production and the generation of building blocks that support cell growth, survival, and differentiation. Cancer cells undergo metabolic reprogramming to sustain rapid proliferation, survive in harsh ... Full text Open Access Link to item Cite

CD36-mediated endocytosis of proteolysis-targeting chimeras.

Journal Article Cell · June 12, 2025 Passive diffusion does not explain why many drugs are too large and/or too polar for rule-breaking membrane penetration, such as proteolysis-targeting chimeras (PROTACs, generally of a molecular weight > 800 Da). Here, using biotinylated chemical-probe-bas ... Full text Link to item Cite

ALDH4A1 functions as an active component of the MPC complex maintaining mitochondrial pyruvate import for TCA cycle entry and tumour suppression.

Journal Article Nat Cell Biol · May 2025 MPC1 and MPC2 are two well-known components of the mitochondrial pyruvate carrier (MPC) complex maintaining MPC activity to transport pyruvate into mitochondria for tricarboxylic acid (TCA) cycle entry in mammalian cells. It is currently unknown whether th ... Full text Open Access Link to item Cite
View All Publications

Recent Grants


Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance

ResearchCollaborator · Awarded by National Cancer Institute · 2023 - 2027

View All Grants

Education, Training & Certifications


National Cheng Kung University (Taiwan) · 2014 Ph.D.